Announcements Trials
Browse Landscape

Phase

Phase 3 3Phase 2 2Phase 4 1Phase 2/3 1

Status

Completed 10Terminated 3Unknown 2Withdrawn 1Not yet recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 1Breast 1

Conditions

Vomiting 1Postoperative Nausea and Vomiting 1Lymphoma, Non-Hodgkin 1Breast Neoplasms 1

Interventions

Cisplatin 270Oxaliplatin 195Carboplatin 191Capecitabine 184Docetaxel 178apatinib 164Paclitaxel 163Bevacizumab 159Gemcitabine 156Radiotherapy 147camrelizumab 146Fluorouracil 144Cyclophosphamide 126Irinotecan 120Drug Therapy 119sintilimab 108Etoposide 99anlotinib 90S 1 (combination) 89Leucovorin 86pembrolizumab 85toripalimab 78Pemetrexed 78Doxorubicin 77tislelizumab 76Dexamethasone 71Trastuzumab 65Neoadjuvant Therapy 65Rituximab 62Cetuximab 62

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Unknown × Ondansetron × Clear all
NCT00324467 2021-07-22

LYTPET

British Columbia Cancer Agency

Phase 2 Unknown
150 enrolled
Lymphoid

Lymphoma, Non-Hodgkin

NCT02234466 2014-09-09

Preoperative Oral Dexamethasone to Improve Recovery After Surgery

University of Manitoba

Phase 2 Unknown
80 enrolled
Breast

Breast Neoplasms, Vomiting, Postoperative Nausea and Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon âš¡